There are 2789 resources available
1784P - Targeting FGFR signaling with FGFR inhibitor-based regimens: UCSD molecular tumor board experience
Presenter: Yuji Uehara
Session: ePoster Display
1785P - Tumor irradiation may improve the sensitivity of liquid biopsy: The analysis of RAS/RAF mutations in plasma obtained from radiotherapy-treated rectal cancer patients
Presenter: Evgeny Imyanitov
Session: ePoster Display
1786P - Distribution of KRAS G12C somatic mutations in 41,913 Chinese cancer patients
Presenter: Yanqiao Zhang
Session: ePoster Display
1787P - RAS precision medicine trans-Atlantic partnership: Multi-centre analysis of RAS and NF1 co-mutations in advanced NSCLC
Presenter: Helen Adderley
Session: ePoster Display
1788P - Physician-reported strategies for overcoming barriers to NGS testing in oncology care
Presenter: Ning Ning
Session: ePoster Display
1789P - The gamma secretase inhibitor AL101 combined with other drugs for dual targeting of Notch dysregulated tumors
Presenter: Renata Ferrarotto
Session: ePoster Display
1790P - Single-cell ex vivo drug response testing platform on fluid samples from patients with solid tumors
Presenter: Lorenz Bankel
Session: ePoster Display
1791P - A phase I pharmacology study of the dual MDMX/MDM2 inhibitor, ALRN 6924, in healthy volunteers
Presenter: Christine Voors-Pette
Session: ePoster Display
1792P - Dual targeting PD-1 and BRD4 with INTASYL self-delivering RNAi elicits persistent anti-tumor immunity in-vivo following complete resolution of tumors
Presenter: Benjamin Cuiffo
Session: ePoster Display
1794P - Rapid diagnosis of liquid biopsy in non-small cell lung cancer by the EGFR-LAMP assay
Presenter: Yuichi Saito
Session: ePoster Display